InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 42233

Wednesday, 11/29/2017 2:32:31 PM

Wednesday, November 29, 2017 2:32:31 PM

Post# of 48316
Merck paid over 8 billion dollars for Cubicin which gave them a portfolio of invalidated patents. Merck is a good company but I think they could have bought many more smaller companies with huge growth potential for that money.....especially Oncosec for just a sliver of that.